Targeting kidney mesangium by nanoparticles of defined size.
about
Critical questions in development of targeted nanoparticle therapeuticsEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsMesoscale nanoparticles selectively target the renal proximal tubule epitheliumMesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic NephropathyBiocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents.Construction and validation of nano gold tripods for molecular imaging of living subjects.Three-dimensional optoacoustic imaging as a new noninvasive technique to study long-term biodistribution of optical contrast agents in small animal models.Passing through the renal clearance barrier: toward ultrasmall sizes with stable ligands for potential clinical applications.Au nanomatryoshkas as efficient near-infrared photothermal transducers for cancer treatment: benchmarking against nanoshellsSurface functionalization of nanoparticles for nanomedicine.Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.Transferrin coated nanoparticles: study of the bionano interface in human plasma.H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.Investigating the optimal size of anticancer nanomedicine.Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapyA comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity.siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNAClinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe.Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane.Enhancing Pharmacokinetics, Tumor Accumulation, and Antitumor Efficacy by Elastin-Like Polypeptide Fusion of Interferon Alpha.Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacyKidney-targeted drug delivery systems.Human anti-α3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis.Structural and oxidative changes in the kidney of crucian carp induced by silicon-based quantum dots.Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression.Challenges and opportunities in the advancement of nanomedicines.PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryA computational model of flow and species transport in the mesangium.Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticleBiofunctionalization of Large Gold Nanorods Realizes Ultrahigh-Sensitivity Optical Imaging Agents.Applications of nanoparticles in the detection and treatment of kidney diseasesNanoparticles as computed tomography contrast agents: current status and future perspectives.Peptide targeted lipid nanoparticles for anticancer drug delivery.Perturbation of physiological systems by nanoparticles.In vitro study of the interaction of heregulin-functionalized magnetic-optical nanorods with MCF7 and MDA-MB-231 cells.Renal allograft fibrosis: biology and therapeutic targets.Role of polymer-drug conjugates in organ-specific delivery systems.Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and kidney pharmacokinetics.
P2860
Q26751896-CD366102-BF9D-43FD-9874-3BE5E4C12738Q26996159-5C58CEA3-A9B2-4C13-97F5-C3A2D33F8301Q27335127-AD1E421A-C4BF-40EF-B995-EBDE3D869A25Q28354224-E01A03D4-4489-4664-9A59-11E5FCE7631DQ30276990-97C56F51-F18D-4BE8-A049-B4FA830C0896Q30419446-6C5B57AD-BB2F-49F5-9042-0DCBF95FA4FAQ30453496-68F8036D-95EF-44FD-9B99-BD08D44EE703Q33559267-8B71825D-1B83-4B10-BEF4-CCD1289E9012Q33824874-84700C6E-24CD-413B-B227-A99E42CB07A2Q33915941-38EDE5EC-2634-45F5-BDC9-60F83D7B824AQ34080235-11FA98BD-C08F-40FC-A956-9481783F8274Q34343298-ED6248E2-7AFB-4AAB-8DD4-4F121ECFFA22Q34351046-8C22A889-0FF2-45CF-9D23-618895FAA8E7Q34383748-14043A3F-AEE5-4824-A5F9-336B792F4BB3Q34442139-6F830C9A-8ED9-49FD-AA68-E24F66FBCCC1Q34626943-968D2FDD-39EB-4350-82A5-8C7E85D99042Q34992848-0CD9CE8D-5587-49C2-862B-0EC7ED5A717EQ35224125-3476B446-1C36-4B81-A66B-F2E5998845D3Q35590083-5B8F91D1-B24B-46D2-9107-3123CA797345Q35778918-51A23413-CE69-4E0A-971D-EEFC874297BAQ35805537-515AF74E-B2B7-4CC0-A0EE-3E66A0937A7BQ36070256-24A581D4-1D7F-4A5D-BA81-B5E5AB7114FBQ36111953-3B5D64C7-A400-473C-A144-6BFD8DCBA553Q36174495-7B291438-2760-4C68-84BE-E633798B373BQ36202455-E8C6B708-F170-45DE-89E1-2C8B8E2C8D84Q36223317-5B177C3A-FAFC-4799-B13A-B7A6D301F584Q36417295-89FBF6AC-49C9-4790-82D5-DE1FF7490973Q36703361-228F22F6-1AC1-47D6-A14D-EA64C77A2880Q36955339-C8E97355-9575-44D3-A168-2C6C5B80EC7BQ36994123-67E1ED10-69A9-4379-A5E1-E2AD8F90A3DDQ37131221-6344ECCB-8829-4320-AF94-C0E6D310C448Q37298541-08F485D0-9348-4322-AC79-9459CEB14762Q37984484-F758CD7E-6192-4387-AA81-7AF6A159A702Q38016810-9CC9D698-751C-4256-BF61-0EDBF552A7DEQ38197488-B7514060-44C3-4701-82B9-359FFECAF078Q38255361-88E50682-10AA-41BF-847C-BD86A6A99F93Q38359455-24525784-3686-40D9-ABBE-C350D602C829Q38365556-A7A6675F-76B6-4600-9300-F9DA44B166ADQ38539866-369FFACF-0FF6-4F74-B225-7CCB7ED82B09Q38686516-50740C4A-07E4-4D10-9748-0C02E45801C3
P2860
Targeting kidney mesangium by nanoparticles of defined size.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting kidney mesangium by nanoparticles of defined size.
@ast
Targeting kidney mesangium by nanoparticles of defined size.
@en
Targeting kidney mesangium by nanoparticles of defined size.
@nl
type
label
Targeting kidney mesangium by nanoparticles of defined size.
@ast
Targeting kidney mesangium by nanoparticles of defined size.
@en
Targeting kidney mesangium by nanoparticles of defined size.
@nl
prefLabel
Targeting kidney mesangium by nanoparticles of defined size.
@ast
Targeting kidney mesangium by nanoparticles of defined size.
@en
Targeting kidney mesangium by nanoparticles of defined size.
@nl
P2093
P2860
P356
P1476
Targeting kidney mesangium by nanoparticles of defined size.
@en
P2093
Chung Hang J Choi
Jonathan E Zuckerman
Mark E Davis
Paul Webster
P2860
P304
P356
10.1073/PNAS.1103573108
P407
P577
2011-04-04T00:00:00Z